Beigene, Ltd. (NASDAQ:ONC) SVP Chan Henry Lee Sells 1,202 Shares of Stock

Beigene, Ltd. (NASDAQ:ONC) SVP Chan Henry Lee sold 1,202 shares of Beigene stock in a transaction on Friday, February 21st. The stock was sold at an average price of $258.04, for a total transaction of $310,164.08. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Beigene Price Performance

NASDAQ:ONC opened at $259.70 on Wednesday. Beigene, Ltd. has a 12 month low of $126.97 and a 12 month high of $265.89. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.72 and a current ratio of 1.93. The firm has a market capitalization of $25.41 billion, a P/E ratio of -31.52, a price-to-earnings-growth ratio of 7.73 and a beta of 0.63.

Beigene Company Profile

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.